Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in enhanced adverse effects for example drowsiness, although the scientific relevance is minimal for most sufferers – keep track of the affected individual for adverse effects (e.If individual are unable to resume thei